Marlborough

Modern offices are gearing more toward an open collaborative environment, but everything starts with the culture a company creates.

A new site in Devens will become the largest parcel of land available for commercial use in the area; and it is highly likely to attract businesses from the life science and technology sectors.

Key to the equation of an innovative workspace is creating an environment that is conducive to both creativity and interaction.

Marlborough medical device manufacturer Boston Scientific announced on Friday it has extended the timeline for its $210-million acquisition of EndoChoice Holdings, Inc. in Georgia.

Despite an increase in revenue by 20 percent, net losses hit $7.9 million for the Marlborough medical device firm ReWalk Robotics in the third quarter.

Marlborough's Boston Scientific has acquired a technology that can enhance endoscopic surgery for precancerous lesions and malignant tumors in the gastrointestinal tract.

Oxford Immunotec posted a 46-percent gain in revenue for the third quarter but still posted a net loss of $4 million, due to expenses related to two acquisitions and an increase in staff.

The city of Marlborough has received more than $3 million in state funds towards Route 20 improvements that the Marlborough Economic Development Corp. says will open the area to $160 million in commercial development.

ReWalk Robotics, the maker of the first publicly-available exoskeleton for paraplegics with U.S. headquarters in Marlborough, last week announced a public stock-and-warrants offering of $12 million.

The mayors of nine Massachusetts cities are among the more than 200 civic and health leaders who urged lawmakers on Thursday to reauthorize a state trust fund aimed at preventing chronic health conditions like diabetes and asthma.